BACE1 expression and activity: Relevance in Alzheimer's disease

Daniele Zacchetti, Evelina Chieregatti, Barbara Bettegazzi, Marija Mihailovich, Vitor Lino Sousa, Fabio Grohovaz, Jacopo Meldolesi

Research output: Contribution to journalArticle

Abstract

A turning point of research in Alzheimer's disease was undoubtedly the discovery of BACE1, the amyloid-β precursor protein-cleaving enzyme that initiates the generation of amyloid-β, the peptide strongly suspected to be responsible for neuronal malfunction and death. Several research groups started a race to identify the best inhibitor of BACE1 activity. On the other hand, basic researchers are evaluating the changes in BACE1 expression and activity with the aim to better understand the pathogenetic process of the disease. Along this second line of research, in the last few years many important results have been reported in various experimental models, as well as in Alzheimer's disease patients. As a consequence, new pathogenetic paradigms have been developed. We have reviewed these reports trying to highlight contrasting viewpoints, data awaiting final confirmation, and promising perspectives.

Original languageEnglish
Pages (from-to)117-126
Number of pages10
JournalNeurodegenerative Diseases
Volume4
Issue number2-3
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Alzheimer Disease
Research
Amyloid beta-Protein Precursor
Amyloid
Theoretical Models
Research Personnel
Peptides
Enzymes

Keywords

  • Astrocytes
  • BACE1
  • Neurons
  • Trafficking
  • Translation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

BACE1 expression and activity : Relevance in Alzheimer's disease. / Zacchetti, Daniele; Chieregatti, Evelina; Bettegazzi, Barbara; Mihailovich, Marija; Sousa, Vitor Lino; Grohovaz, Fabio; Meldolesi, Jacopo.

In: Neurodegenerative Diseases, Vol. 4, No. 2-3, 06.2007, p. 117-126.

Research output: Contribution to journalArticle

Zacchetti, Daniele ; Chieregatti, Evelina ; Bettegazzi, Barbara ; Mihailovich, Marija ; Sousa, Vitor Lino ; Grohovaz, Fabio ; Meldolesi, Jacopo. / BACE1 expression and activity : Relevance in Alzheimer's disease. In: Neurodegenerative Diseases. 2007 ; Vol. 4, No. 2-3. pp. 117-126.
@article{cb2a3eea8ea741bf86a91482b43cb5a1,
title = "BACE1 expression and activity: Relevance in Alzheimer's disease",
abstract = "A turning point of research in Alzheimer's disease was undoubtedly the discovery of BACE1, the amyloid-β precursor protein-cleaving enzyme that initiates the generation of amyloid-β, the peptide strongly suspected to be responsible for neuronal malfunction and death. Several research groups started a race to identify the best inhibitor of BACE1 activity. On the other hand, basic researchers are evaluating the changes in BACE1 expression and activity with the aim to better understand the pathogenetic process of the disease. Along this second line of research, in the last few years many important results have been reported in various experimental models, as well as in Alzheimer's disease patients. As a consequence, new pathogenetic paradigms have been developed. We have reviewed these reports trying to highlight contrasting viewpoints, data awaiting final confirmation, and promising perspectives.",
keywords = "Astrocytes, BACE1, Neurons, Trafficking, Translation",
author = "Daniele Zacchetti and Evelina Chieregatti and Barbara Bettegazzi and Marija Mihailovich and Sousa, {Vitor Lino} and Fabio Grohovaz and Jacopo Meldolesi",
year = "2007",
month = "6",
doi = "10.1159/000101836",
language = "English",
volume = "4",
pages = "117--126",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - BACE1 expression and activity

T2 - Relevance in Alzheimer's disease

AU - Zacchetti, Daniele

AU - Chieregatti, Evelina

AU - Bettegazzi, Barbara

AU - Mihailovich, Marija

AU - Sousa, Vitor Lino

AU - Grohovaz, Fabio

AU - Meldolesi, Jacopo

PY - 2007/6

Y1 - 2007/6

N2 - A turning point of research in Alzheimer's disease was undoubtedly the discovery of BACE1, the amyloid-β precursor protein-cleaving enzyme that initiates the generation of amyloid-β, the peptide strongly suspected to be responsible for neuronal malfunction and death. Several research groups started a race to identify the best inhibitor of BACE1 activity. On the other hand, basic researchers are evaluating the changes in BACE1 expression and activity with the aim to better understand the pathogenetic process of the disease. Along this second line of research, in the last few years many important results have been reported in various experimental models, as well as in Alzheimer's disease patients. As a consequence, new pathogenetic paradigms have been developed. We have reviewed these reports trying to highlight contrasting viewpoints, data awaiting final confirmation, and promising perspectives.

AB - A turning point of research in Alzheimer's disease was undoubtedly the discovery of BACE1, the amyloid-β precursor protein-cleaving enzyme that initiates the generation of amyloid-β, the peptide strongly suspected to be responsible for neuronal malfunction and death. Several research groups started a race to identify the best inhibitor of BACE1 activity. On the other hand, basic researchers are evaluating the changes in BACE1 expression and activity with the aim to better understand the pathogenetic process of the disease. Along this second line of research, in the last few years many important results have been reported in various experimental models, as well as in Alzheimer's disease patients. As a consequence, new pathogenetic paradigms have been developed. We have reviewed these reports trying to highlight contrasting viewpoints, data awaiting final confirmation, and promising perspectives.

KW - Astrocytes

KW - BACE1

KW - Neurons

KW - Trafficking

KW - Translation

UR - http://www.scopus.com/inward/record.url?scp=34347205228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347205228&partnerID=8YFLogxK

U2 - 10.1159/000101836

DO - 10.1159/000101836

M3 - Article

C2 - 17596706

AN - SCOPUS:34347205228

VL - 4

SP - 117

EP - 126

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

SN - 1660-2854

IS - 2-3

ER -